Joseph Irudayaraj, a Purdue University associate professor, developed a nanoscale - multifunctional probe, 1,000 times smaller than the diameter of a human hair, that contains the antibody Herceptin; a drug used in the treatment of cancer. The probe can help pinpoint the location of cancerous tumors and might one day be able to directly attack cancer cells.
"If we have a tumor, these probes should have the ability to latch on to it," Irudayaraj said. "The probe could carry drugs to target, treat as well as reveal cancer cells."
The probes would be injected into the body through a saline fluid and the Herceptin would find and attach to protein markers on the surface of cancer cells.
The probes are not yet on the market, "..the next step would be to run a series of tests in mice models to determine the dose and stability of the probes." Intern Daily
"If we have a tumor, these probes should have the ability to latch on to it," Irudayaraj said. "The probe could carry drugs to target, treat as well as reveal cancer cells."
The probes would be injected into the body through a saline fluid and the Herceptin would find and attach to protein markers on the surface of cancer cells.
The probes are not yet on the market, "..the next step would be to run a series of tests in mice models to determine the dose and stability of the probes." Intern Daily
0 comments:
Post a Comment